Stock Market News Today Live Updates: GIFT Nifty Points To Gap-Up Open For Nifty, Sensex; Brent Crude Rebounds Near $84 A Barrel

Investors will track results from Eicher Motors, Honeywell Automation India, KPIT Technologies, Zensar Technologies, Hexaware Technologies and Garden Reach Shipbuilders as the earnings season gathers pace.

Adani Enterprises, Adani Ports, Asian Paints, Dabur India, Eicher Motors, KPIT Technologies, Waaree Energies, Piramal Pharma, Prestige Estates, Syngene International and several other companies are scheduled to report quarterly earnings today.

Several companies including VST Industries, Colgate-Palmolive (India), Apollo Tyres, Syngene International, Redington, Honeywell Automation India and Can Fin Homes are scheduled to hold their annual general meetings today.

Manipal Health Enterprises' Rs 9,275.22 crore initial public offering opens for subscription today and closes on July 31. The issue comprises a fresh issue and an offer for sale.

Tatva Chintan Pharma Chem will be excluded from the Additional Surveillance Measure framework, according to the latest exchange notification.

Punjab National Bank's board will meet to consider a proposal for raising funds. IndoStar Capital Finance, Syrma SGS Technology and Madhya Bharat Agro Products will also consider fundraising proposals.

Route Mobile's board is scheduled to meet to consider an interim dividend, making the stock one of the key corporate action counters to watch during the session.

The U.S. Department of Commerce preliminarily imposed a 3.68% countervailing duty on Graphite India's exports of large diameter graphite electrodes.

Central Depository Services received SEBI approval for the joint venture agreement involving subsidiary Centrico Insurance Repository and Shoveltech Solutions, along with approval for Rs 25 lakh towards MVP development.

Info Edge (India) said the National Company Law Appellate Tribunal allowed its appeal relating to the proposed amalgamation of four wholly owned subsidiaries with the company.

Tanla Platforms said its subsidiary approved the acquisition of 100% of ValueFirst Middle East FZC for Rs 148.52 crore. The transaction is expected to close by the second quarter of FY27.

The government extended the tenure of NTPC Chairman and Managing Director Gurdeep Singh by six months from Aug. 1, 2026, or until a regular incumbent takes charge.

ONGC's board approved providing a USD 500 million parent company guarantee in favour of Saudi Aramco on behalf of MRPL to facilitate crude oil imports through Aug. 2028.

Dalmia Bharat said subsidiary Dalmia Cement (Bharat) Ltd. received the Letter of Intent after being identified as the successful resolution applicant for Bhilai Jaypee Cement Ltd.

Rail Vikas Nigam received the Letter of Acceptance from East Central Railway for a Rs 358.97 crore railway doubling project between Kundawa Chainpur and Raxaul.

RailTel Corporation received a Rs 43.9 crore work order from the Odisha Police for deployment of IT, cyber forensic and finance professionals. The contract is scheduled for completion by Aug. 30, 2029.

Dynacons Systems & Solutions secured a Rs 267.58 crore contract from NPCI for data centre augmentation, including enterprise server infrastructure, along with seven years of support and warranty.

JPMorgan and Kotak Securities retained positive recommendations on Cipla after the company received approval for gAdvair in the US market. Both brokerages said the approval supports the company's growth outlook in the US business.

• JPMorgan: Maintain Overweight, TP Rs 1,600
  • First DPI approval from US plant.
  • Product opportunity remains meaningful.
  • Company progressing well toward FY27 guidance.
• Kotak Securities: Maintain Buy, TP Rs 1,675
  • gAdvair approval is another milestone.
  • Expects meaningful US sales contribution over FY27-28.
  • Continues to rank Cipla among top picks.

RPG Life Sciences (Q1, Consolidated YoY)

• Revenue up 15.8% to Rs 196 crore versus Rs 169 crore.
• EBITDA up 22% to Rs 43 crore versus Rs 35 crore.
• Margin at 22.1% versus 21%.
• Net Profit up 17% to Rs 30.8 crore versus Rs 26.3 crore.

Morgan Stanley, Goldman Sachs and Macquarie revised their views on Avenue Supermarts after management commentary. Brokerages lowered earnings assumptions or target prices, while highlighting slower store additions, like-for-like sales expectations and the company's approach towards quick commerce.

• Morgan Stanley: Maintain Overweight, cut TP to Rs 4,464 from Rs 4,827
  • Cuts FY27 store additions to 75.
  • Lowers same-store sales growth assumptions.
  • Reduces FY27-29 EPS estimates.
• Goldman Sachs: Maintain Sell, cut TP to Rs 3,800 from Rs 4,000
  • Store addition plans below expectations.
  • Company more open to long-term leases.
  • Limited scope for SSSG acceleration.
  • Quick commerce strategy remains conservative.
• Macquarie: Maintain Underperform, TP Rs 3,250
  • Targets 15% annual store additions.
  • Expects SSSG around eight percent.
  • Continues to focus on profitable growth over quick commerce.

Sanofi Consumer (Q1, YoY)

• Revenue up 6.7% to Rs 236 crore versus Rs 221 crore.
• EBITDA up 27.2% to Rs 89.3 crore versus Rs 70.2 crore.
• Margin at 37.9% versus 31.8%.
• Net Profit up 13.3% to Rs 68.8 crore versus Rs 60.7 crore.

Jefferies, Citi and Morgan Stanley retained positive recommendations on Varun Beverages despite weaker quarterly growth. Brokerages cited management's confidence in demand recovery, international business growth and improved momentum in July.

• Jefferies: Maintain Buy, TP Rs 615
  • Calls correction excessive.
  • Weak April weather hurt volumes while May and June remained strong.
  • International business cushioned weakness.
  • July momentum remains encouraging.
• Citi: Maintain Buy, cut TP to Rs 580 from Rs 640
  • Q2 below expectations.
  • India growth debate persists.
  • International business continues to perform strongly.
  • Long-term category outlook remains attractive.
• Morgan Stanley: Maintain Overweight, TP Rs 557
  • Positive commentary on July demand.
  • Double-digit growth momentum expected to continue.
  • Current correction already reflects weaker India growth.

Trualt Bioenergy (Q1, Consolidated YoY)

• Revenue at Rs 627 crore versus Rs 304 crore.
• EBITDA at Rs 132.8 crore versus Rs 41.5 crore.
• Margin at 21.2% versus 13.7%.
• Net Profit at Rs 57 crore versus Rs 4.7 crore.
• Appoints Mallikarjun Dyaberi as Chairman for one year.

Jefferies and Citi reiterated Buy on Cholamandalam Investment & Finance, citing asset quality, margins and growth. Morgan Stanley raised its target price while retaining Equal-weight. Macquarie maintained Underperform despite describing the quarter as steady.

• Jefferies: Maintain Buy, raise TP to Rs 2,100 from Rs 1,960
  • Profit beat driven by broad-based momentum.
  • Healthy AUM growth.
  • Stable margin outlook.
  • FY27 credit costs may undershoot guidance.
  • Remains a top NBFC pick.
• Citi: Maintain Buy, raise TP to Rs 2,100 from Rs 1,945
  • Growth, NIMs and credit costs remained strong.
  • Seasonal asset-quality deterioration was limited.
  • NIMs likely to stay above guidance.
  • Investment phase continues.
• Morgan Stanley: Maintain Equal-weight, raise TP to Rs 1,900 from Rs 1,720
  • Good quarter.
  • Raises FY27 forecasts sharply.
  • Limited upside remains due to macro risks and rate sensitivity.
• Macquarie: Maintain Underperform, TP Rs 1,495
  • Operating leverage drove an in-line quarter.
  • Growth momentum remains intact.
  • Margins remain defensible.
  • Seasonal stress easing with improving loss trajectory.

PTC India Financial (Q1, Consolidated YoY)

• Total Income down 27.5% to Rs 103 crore versus Rs 142 crore.
• Net Profit down 70.6% to Rs 40 crore versus Rs 136 crore.

S H Kelkar (Q1, Consolidated YoY)

• Revenue up 13.9% to Rs 662 crore versus Rs 581 crore.
• EBITDA up 17.3% to Rs 88 crore versus Rs 75 crore.
• Margin at 13.3% versus 12.9%.
• Net Profit up 77.3% to Rs 45.4 crore versus Rs 25.6 crore.
• • One-time gain of Rs 30 crore in Q1.

CLSA, Jefferies and Citi maintained positive ratings on Larsen & Toubro following its first-quarter earnings. Brokerages highlighted the order inflow, backlog and management's revenue guidance, while noting margins remained broadly resilient.

• Jefferies: Maintain Buy, raise TP to Rs 5,000 from Rs 4,885
  • Margins remained intact despite revenue miss.
  • FY27 revenue guidance maintained.
  • H2 expected to be stronger.
  • Stock could recover further if geopolitical tensions ease.
• CLSA: Maintain Outperform, TP Rs 4,842
  • Strong Q1 order inflow surprise.
  • Europe opportunity and India's capex cycle expand addressable market.
  • Current weakness seen as a buying opportunity.
  • Calls L&T the most undervalued large-cap industrial.
  • Order backlog of $78 billion remains strong.
• Citi: Maintain Buy, TP Rs 4,650
  • Resilient Q1 performance.
  • Order inflow outlook remains constructive.
  • Supply-chain cost pressures seen as manageable.
  • Full-year margin guidance maintained.

AGI Greenpac appointed Shashvat Somany as Joint Managing Director for a five-year term beginning Oct. 1, according to its exchange filing.

Brokerages retained positive ratings on Hindustan Unilever after its quarterly results. Goldman Sachs, Citi, Jefferies and Macquarie maintained Buy recommendations, while Morgan Stanley stayed Equal-weight. Most brokerages lowered target prices but said demand trends remain stable and growth should improve.

• Jefferies: Maintain Buy, TP Rs 2,850
  • Seven percent share price fall appears excessive given the limited EBITDA miss.
  • Weakness in some segments was offset elsewhere.
  • Growth and profitability have improved consistently over recent quarters.
  • Management commentary was constructive with stable demand and margins.
• Goldman Sachs: Maintain Buy, cut TP to Rs 2,450 from Rs 2,725
  • Expects revenue growth to accelerate further in FY27.
  • Home Care growth likely to improve as pricing kicks in.
  • Encouraged by Beauty & Wellbeing recovery.
  • Foods steady while Personal Care remains weak.
  • EBITDA margins expected to remain resilient despite input cost inflation.
• Citi: Maintain Buy, cut TP to Rs 2,650 from Rs 2,750
  • Growth momentum remains intact.
  • FY27 outlook remains constructive.
  • Stable demand outlook.
  • Improving execution, premiumisation and channel transformation.
• Morgan Stanley: Maintain Equal-weight, TP Rs 2,480
  • Management commentary remains optimistic.
  • Demand conditions expected to stay stable.
  • Inflation has not yet impacted consumption.
  • Rural and urban demand remain resilient.
  • Monsoon and geopolitical risks remain key monitorables.
• Macquarie: Maintain Outperform, TP Rs 2,860
  • Q1 broadly in line; volume growth moderated sequentially.
  • Continued weakness in soaps due to inflation remains a concern.
  • Positive on stable FMCG demand outlook.
  • Premium portfolio continues to outperform.
  • Greater clarity on volume recovery is the key near-term trigger.

AGI Greenpac (Q1, Consolidated YoY)

• Revenue up 14.2% to Rs 785 crore versus Rs 688 crore.
• EBITDA up 23.1% to Rs 175 crore versus Rs 142 crore.
• Margin at 22.3% versus 20.7.
• Net Profit up 11.8% to Rs 99.4 crore versus Rs 88.9 crore.

VST Industries (Q1, YoY)

• Net Revenue down 13.5% to Rs 256 crore versus Rs 296 crore.
• EBITDA down 35.5% to Rs 49.7 crore versus Rs 77 crore.
• Margin at 19.4% versus 25.8%.
• Net Profit down 24.4% to Rs 42.4 crore versus Rs 56.1 crore.

Birlasoft (Q1, Consolidated QoQ)

• Revenue up 2.3% to Rs 1,379 crore versus Rs 1,349 crore.
• EBIT down 11.5% to Rs 204 crore versus Rs 230 crore.
• EBIT Margin at 14.8% versus 17%.
• Net profit down 8.5% to Rs 161 crore versus Rs 176 crore.

DCM Shriram (Q1, Consolidated YoY)

• Revenue up 9.3% to Rs 3,565 crore versus Rs 3,262 crore.
• EBITDA up 10.9% to Rs 336 crore versus Rs 303 crore.
• Margin at 9.4% versus 9.3%.
• Net profit at Rs 693 crore versus Rs 113 crore.

Phoenix Mills (Q1, Consolidated YoY)

• Revenue up 12.8% to Rs 1,075 crore versus Rs 953 crore.
• EBITDA up 13.5% to Rs 641 crore versus Rs 565 crore.
• Margin at 59.6% versus 59.2%.
• Net profit up 23.2% to Rs 297 crore versus Rs 241 crore.

Tata Capital (Q1, Consolidated YoY)

• Total Income up 15% to Rs 8,825 crore versus Rs 7,692 crore.
• Net profit up 56.3% to Rs 1,547 crore versus Rs 990 crore.

Paradeep Phosphates (Q1, Consolidated YoY)

• Revenue up 36% to Rs 6,124 crore versus Rs 4,504 crore.
• EBITDA up 24% to Rs 721 crore versus Rs 581 crore.
• Margin at 11.8% versus 12.9%.
• Net profit up 23.8% to Rs 393 crore versus Rs 317 crore.

• Board approved setting up a 15,000 MTPA Aluminium Fluoride manufacturing plant at Paradeep with an estimated investment of Rs 250 crore.

Larsen & Toubro's board approved the merger of wholly owned subsidiary L&T Power Development Ltd. with the company. The proposal is subject to regulatory and statutory approvals.

Larsen & Toubro (Q1, Consolidated YoY)

• Revenue up 6.7% to Rs 67,942 crore versus Rs 63,679 crore.
• EBITDA down 3.2% to Rs 6,117 crore versus Rs 6,318 crore.
• Margin at 9% versus 9.9%.
• Net profit up 14% to Rs 4,123 crore versus Rs 3,617 crore.

• Order book as on June 30 at Rs 7.79 lakh crore.
• Order inflow up 14% to Rs 1.08 lakh crore YoY.

• Investors will track the US Federal Reserve’s policy decision for signals on interest rates amid higher crude oil prices and geopolitical uncertainty.
• A sustained rise in energy costs could affect the inflation outlook and the central bank’s policy stance. Middle East developments and crude oil prices will also remain in focus.

S&P 500 futures edged higher, while Nasdaq-100 futures traded little changed during Asian hours. Dow futures fell 38 points, or about 0.1%.

• The Dow Jones Industrial Average gained more than 500 points and advanced for a third straight session ahead of the US Federal Reserve’s policy decision.
• The Nasdaq Composite fell for a fifth consecutive session as semiconductor stocks remained under pressure.

Brent crude rose more than 4% to around $87.50 per barrel as markets reacted to renewed tensions in the Middle East. Oil recovered after its steepest three-day decline since April 2020.

• US Central Command said American forces intercepted multiple ballistic missiles launched by Iran at US military personnel in the Middle East. The US military later carried out retaliatory strikes against Iran.
• The developments led traders to reassess risks to global energy supplies.

• South Korea’s Kospi rose 2.11%, while Japan’s Nikkei 225 gained 1.08%. Australia’s ASX 200 advanced 1.07%.
• Investors focused on the US Federal Reserve’s policy announcement, while renewed Middle East tensions and a rebound in oil prices remained in focus.

GIFT Nifty traded at 24,247.50, about 260 points above the Nifty 50’s Tuesday close of 23,987.60.